A Meta-Analysis of Randomized and Observational Studies: Aspirin Protects from Cardiac Surgery-Associated Acute Kidney Injury
Antiplatelet therapy is critical in the management of coronary artery diseases. For patients undergoing cardiac surgeries, including coronary artery bypass graft (CABG) and valve replacement, controversy remains in preoperative antiplatelet therapy concerning risk of bleeding. For safety concern, as...
Gespeichert in:
Veröffentlicht in: | The Heart surgery forum 2019-07, Vol.22 (4), p.E301-E307 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | E307 |
---|---|
container_issue | 4 |
container_start_page | E301 |
container_title | The Heart surgery forum |
container_volume | 22 |
creator | Liu, Huijiao Li, Jianwei Chen, Miaolian Yang, Ting Ruan, Zongfa Su, Jiahao Xing, Yichun |
description | Antiplatelet therapy is critical in the management of coronary artery diseases. For patients undergoing cardiac surgeries, including coronary artery bypass graft (CABG) and valve replacement, controversy remains in preoperative antiplatelet therapy concerning risk of bleeding. For safety concern, aspirin is recommended to be withdrawn 5 to 10 days before a cardiac surgery. Recent studies, however, indicate that preoperative aspirin may have a protective effect on cardiac surgery-associated acute kidney injury (CSA-AKI).
To estimate the efficacy of preoperative aspirin in preventing CSA-AKI.
Eligible studies included randomized controlled trials (RCTs) and observational studies (OSs) of patients, who had undergone CABG, valve replacement, or combined surgery. These studies compared preoperative aspirin with placebo/no aspirin and reported the least incidence of CSA-AKI. One RCT and five OSs met the inclusion criteria. Data retrieved suggested that aspirin prescribed within five days before cardiac surgery decreased post-operative renal failure [odds ratio (OR), 0.67; 95% confidence interval (CI), 0.50-0.89; P < 0.01] and 30-day mortality (OR, 0.64; 95% CI, 0.53-0.77; P < 0.01). One RCT and three OSs suggested aspirin protected from major adverse cardiocerebral events (MACE) (OR, 0.88; 95% CI, 0.76-1.01; P = 0.07). One RCT and two OSs suggested aspirin did not increase risk of re-exploration for bleeding (OR, 1.01; 95% CI, 0.76-1.34; P = 0.95).
Preoperative low-dose aspirin decreases post-operative CSA-AKI, mortality, and MACE without increasing the risk of re-exploration. But most of the studies are observational. They lack a uniformed standard on prescription of aspirin and outcomes measurement. No stratification analysis is performed concerning different types of surgical procedures and comorbidities. More randomized controlled trials are necessary to confirm the efficacy and safety of preoperative aspirin prescription. |
doi_str_mv | 10.1532/hsf.2419 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2271854961</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2271854961</sourcerecordid><originalsourceid>FETCH-LOGICAL-c283t-42a5b20b44af6cb25eb85454c35ef68d038e54f5b25f5360a21b5059cbc71edb3</originalsourceid><addsrcrecordid>eNpFkM1O3DAYRS1UBBSQ-gTIy24y9U_sSdhFI9qigkD8rCPb-dx6NIkHf06lIPHuzahDu7p3cXQWh5BPnC24kuLLL_QLUfL6gJxwJUShtRYf5s_qqpCK82PyEXHNmNBC6CNyLLmsK1YvT8hbQ28hm6IZzGbCgDR6-mCGLvbhFTo6P3pnEdJvk0OcGfqYxy4AXtIGtyGFgd6nmMFlpD7Fnq5M6oJx9HFMPyFNRYMYXTB5djVuzEB_hG6AiV4P6zFNZ-TQmw3C-X5PyfPXq6fV9-Lm7tv1qrkpnKhkLkphlBXMlqXx2lmhwFaqVKWTCryuOiYrUKWfGeWV1MwIbhVTtbNuyaGz8pR8_uvdpvgyAua2D-hgszEDxBFbIZZ8Ntaa_0ddiogJfLtNoTdpajlrd7HbOXa7iz2jF3vraHvo_oHvdeUfUSB7aA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2271854961</pqid></control><display><type>article</type><title>A Meta-Analysis of Randomized and Observational Studies: Aspirin Protects from Cardiac Surgery-Associated Acute Kidney Injury</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Liu, Huijiao ; Li, Jianwei ; Chen, Miaolian ; Yang, Ting ; Ruan, Zongfa ; Su, Jiahao ; Xing, Yichun</creator><creatorcontrib>Liu, Huijiao ; Li, Jianwei ; Chen, Miaolian ; Yang, Ting ; Ruan, Zongfa ; Su, Jiahao ; Xing, Yichun</creatorcontrib><description>Antiplatelet therapy is critical in the management of coronary artery diseases. For patients undergoing cardiac surgeries, including coronary artery bypass graft (CABG) and valve replacement, controversy remains in preoperative antiplatelet therapy concerning risk of bleeding. For safety concern, aspirin is recommended to be withdrawn 5 to 10 days before a cardiac surgery. Recent studies, however, indicate that preoperative aspirin may have a protective effect on cardiac surgery-associated acute kidney injury (CSA-AKI).
To estimate the efficacy of preoperative aspirin in preventing CSA-AKI.
Eligible studies included randomized controlled trials (RCTs) and observational studies (OSs) of patients, who had undergone CABG, valve replacement, or combined surgery. These studies compared preoperative aspirin with placebo/no aspirin and reported the least incidence of CSA-AKI. One RCT and five OSs met the inclusion criteria. Data retrieved suggested that aspirin prescribed within five days before cardiac surgery decreased post-operative renal failure [odds ratio (OR), 0.67; 95% confidence interval (CI), 0.50-0.89; P < 0.01] and 30-day mortality (OR, 0.64; 95% CI, 0.53-0.77; P < 0.01). One RCT and three OSs suggested aspirin protected from major adverse cardiocerebral events (MACE) (OR, 0.88; 95% CI, 0.76-1.01; P = 0.07). One RCT and two OSs suggested aspirin did not increase risk of re-exploration for bleeding (OR, 1.01; 95% CI, 0.76-1.34; P = 0.95).
Preoperative low-dose aspirin decreases post-operative CSA-AKI, mortality, and MACE without increasing the risk of re-exploration. But most of the studies are observational. They lack a uniformed standard on prescription of aspirin and outcomes measurement. No stratification analysis is performed concerning different types of surgical procedures and comorbidities. More randomized controlled trials are necessary to confirm the efficacy and safety of preoperative aspirin prescription.</description><identifier>ISSN: 1098-3511</identifier><identifier>EISSN: 1522-6662</identifier><identifier>DOI: 10.1532/hsf.2419</identifier><identifier>PMID: 31398097</identifier><language>eng</language><publisher>United States</publisher><subject>Acute Kidney Injury - prevention & control ; Aspirin - administration & dosage ; Cause of Death ; Coma - etiology ; Coronary Artery Bypass - adverse effects ; Heart Arrest - etiology ; Heart Block - etiology ; Heart Valve Prosthesis Implantation - adverse effects ; Humans ; Ischemic Attack, Transient - etiology ; Myocardial Infarction - etiology ; Observational Studies as Topic ; Platelet Aggregation Inhibitors - administration & dosage ; Postoperative Complications - etiology ; Postoperative Complications - prevention & control ; Randomized Controlled Trials as Topic</subject><ispartof>The Heart surgery forum, 2019-07, Vol.22 (4), p.E301-E307</ispartof><rights>2019 Forum Multimedia Publishing, LLC</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c283t-42a5b20b44af6cb25eb85454c35ef68d038e54f5b25f5360a21b5059cbc71edb3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31398097$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liu, Huijiao</creatorcontrib><creatorcontrib>Li, Jianwei</creatorcontrib><creatorcontrib>Chen, Miaolian</creatorcontrib><creatorcontrib>Yang, Ting</creatorcontrib><creatorcontrib>Ruan, Zongfa</creatorcontrib><creatorcontrib>Su, Jiahao</creatorcontrib><creatorcontrib>Xing, Yichun</creatorcontrib><title>A Meta-Analysis of Randomized and Observational Studies: Aspirin Protects from Cardiac Surgery-Associated Acute Kidney Injury</title><title>The Heart surgery forum</title><addtitle>Heart Surg Forum</addtitle><description>Antiplatelet therapy is critical in the management of coronary artery diseases. For patients undergoing cardiac surgeries, including coronary artery bypass graft (CABG) and valve replacement, controversy remains in preoperative antiplatelet therapy concerning risk of bleeding. For safety concern, aspirin is recommended to be withdrawn 5 to 10 days before a cardiac surgery. Recent studies, however, indicate that preoperative aspirin may have a protective effect on cardiac surgery-associated acute kidney injury (CSA-AKI).
To estimate the efficacy of preoperative aspirin in preventing CSA-AKI.
Eligible studies included randomized controlled trials (RCTs) and observational studies (OSs) of patients, who had undergone CABG, valve replacement, or combined surgery. These studies compared preoperative aspirin with placebo/no aspirin and reported the least incidence of CSA-AKI. One RCT and five OSs met the inclusion criteria. Data retrieved suggested that aspirin prescribed within five days before cardiac surgery decreased post-operative renal failure [odds ratio (OR), 0.67; 95% confidence interval (CI), 0.50-0.89; P < 0.01] and 30-day mortality (OR, 0.64; 95% CI, 0.53-0.77; P < 0.01). One RCT and three OSs suggested aspirin protected from major adverse cardiocerebral events (MACE) (OR, 0.88; 95% CI, 0.76-1.01; P = 0.07). One RCT and two OSs suggested aspirin did not increase risk of re-exploration for bleeding (OR, 1.01; 95% CI, 0.76-1.34; P = 0.95).
Preoperative low-dose aspirin decreases post-operative CSA-AKI, mortality, and MACE without increasing the risk of re-exploration. But most of the studies are observational. They lack a uniformed standard on prescription of aspirin and outcomes measurement. No stratification analysis is performed concerning different types of surgical procedures and comorbidities. More randomized controlled trials are necessary to confirm the efficacy and safety of preoperative aspirin prescription.</description><subject>Acute Kidney Injury - prevention & control</subject><subject>Aspirin - administration & dosage</subject><subject>Cause of Death</subject><subject>Coma - etiology</subject><subject>Coronary Artery Bypass - adverse effects</subject><subject>Heart Arrest - etiology</subject><subject>Heart Block - etiology</subject><subject>Heart Valve Prosthesis Implantation - adverse effects</subject><subject>Humans</subject><subject>Ischemic Attack, Transient - etiology</subject><subject>Myocardial Infarction - etiology</subject><subject>Observational Studies as Topic</subject><subject>Platelet Aggregation Inhibitors - administration & dosage</subject><subject>Postoperative Complications - etiology</subject><subject>Postoperative Complications - prevention & control</subject><subject>Randomized Controlled Trials as Topic</subject><issn>1098-3511</issn><issn>1522-6662</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkM1O3DAYRS1UBBSQ-gTIy24y9U_sSdhFI9qigkD8rCPb-dx6NIkHf06lIPHuzahDu7p3cXQWh5BPnC24kuLLL_QLUfL6gJxwJUShtRYf5s_qqpCK82PyEXHNmNBC6CNyLLmsK1YvT8hbQ28hm6IZzGbCgDR6-mCGLvbhFTo6P3pnEdJvk0OcGfqYxy4AXtIGtyGFgd6nmMFlpD7Fnq5M6oJx9HFMPyFNRYMYXTB5djVuzEB_hG6AiV4P6zFNZ-TQmw3C-X5PyfPXq6fV9-Lm7tv1qrkpnKhkLkphlBXMlqXx2lmhwFaqVKWTCryuOiYrUKWfGeWV1MwIbhVTtbNuyaGz8pR8_uvdpvgyAua2D-hgszEDxBFbIZZ8Ntaa_0ddiogJfLtNoTdpajlrd7HbOXa7iz2jF3vraHvo_oHvdeUfUSB7aA</recordid><startdate>20190725</startdate><enddate>20190725</enddate><creator>Liu, Huijiao</creator><creator>Li, Jianwei</creator><creator>Chen, Miaolian</creator><creator>Yang, Ting</creator><creator>Ruan, Zongfa</creator><creator>Su, Jiahao</creator><creator>Xing, Yichun</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20190725</creationdate><title>A Meta-Analysis of Randomized and Observational Studies: Aspirin Protects from Cardiac Surgery-Associated Acute Kidney Injury</title><author>Liu, Huijiao ; Li, Jianwei ; Chen, Miaolian ; Yang, Ting ; Ruan, Zongfa ; Su, Jiahao ; Xing, Yichun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c283t-42a5b20b44af6cb25eb85454c35ef68d038e54f5b25f5360a21b5059cbc71edb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Acute Kidney Injury - prevention & control</topic><topic>Aspirin - administration & dosage</topic><topic>Cause of Death</topic><topic>Coma - etiology</topic><topic>Coronary Artery Bypass - adverse effects</topic><topic>Heart Arrest - etiology</topic><topic>Heart Block - etiology</topic><topic>Heart Valve Prosthesis Implantation - adverse effects</topic><topic>Humans</topic><topic>Ischemic Attack, Transient - etiology</topic><topic>Myocardial Infarction - etiology</topic><topic>Observational Studies as Topic</topic><topic>Platelet Aggregation Inhibitors - administration & dosage</topic><topic>Postoperative Complications - etiology</topic><topic>Postoperative Complications - prevention & control</topic><topic>Randomized Controlled Trials as Topic</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liu, Huijiao</creatorcontrib><creatorcontrib>Li, Jianwei</creatorcontrib><creatorcontrib>Chen, Miaolian</creatorcontrib><creatorcontrib>Yang, Ting</creatorcontrib><creatorcontrib>Ruan, Zongfa</creatorcontrib><creatorcontrib>Su, Jiahao</creatorcontrib><creatorcontrib>Xing, Yichun</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Heart surgery forum</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Huijiao</au><au>Li, Jianwei</au><au>Chen, Miaolian</au><au>Yang, Ting</au><au>Ruan, Zongfa</au><au>Su, Jiahao</au><au>Xing, Yichun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Meta-Analysis of Randomized and Observational Studies: Aspirin Protects from Cardiac Surgery-Associated Acute Kidney Injury</atitle><jtitle>The Heart surgery forum</jtitle><addtitle>Heart Surg Forum</addtitle><date>2019-07-25</date><risdate>2019</risdate><volume>22</volume><issue>4</issue><spage>E301</spage><epage>E307</epage><pages>E301-E307</pages><issn>1098-3511</issn><eissn>1522-6662</eissn><abstract>Antiplatelet therapy is critical in the management of coronary artery diseases. For patients undergoing cardiac surgeries, including coronary artery bypass graft (CABG) and valve replacement, controversy remains in preoperative antiplatelet therapy concerning risk of bleeding. For safety concern, aspirin is recommended to be withdrawn 5 to 10 days before a cardiac surgery. Recent studies, however, indicate that preoperative aspirin may have a protective effect on cardiac surgery-associated acute kidney injury (CSA-AKI).
To estimate the efficacy of preoperative aspirin in preventing CSA-AKI.
Eligible studies included randomized controlled trials (RCTs) and observational studies (OSs) of patients, who had undergone CABG, valve replacement, or combined surgery. These studies compared preoperative aspirin with placebo/no aspirin and reported the least incidence of CSA-AKI. One RCT and five OSs met the inclusion criteria. Data retrieved suggested that aspirin prescribed within five days before cardiac surgery decreased post-operative renal failure [odds ratio (OR), 0.67; 95% confidence interval (CI), 0.50-0.89; P < 0.01] and 30-day mortality (OR, 0.64; 95% CI, 0.53-0.77; P < 0.01). One RCT and three OSs suggested aspirin protected from major adverse cardiocerebral events (MACE) (OR, 0.88; 95% CI, 0.76-1.01; P = 0.07). One RCT and two OSs suggested aspirin did not increase risk of re-exploration for bleeding (OR, 1.01; 95% CI, 0.76-1.34; P = 0.95).
Preoperative low-dose aspirin decreases post-operative CSA-AKI, mortality, and MACE without increasing the risk of re-exploration. But most of the studies are observational. They lack a uniformed standard on prescription of aspirin and outcomes measurement. No stratification analysis is performed concerning different types of surgical procedures and comorbidities. More randomized controlled trials are necessary to confirm the efficacy and safety of preoperative aspirin prescription.</abstract><cop>United States</cop><pmid>31398097</pmid><doi>10.1532/hsf.2419</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1098-3511 |
ispartof | The Heart surgery forum, 2019-07, Vol.22 (4), p.E301-E307 |
issn | 1098-3511 1522-6662 |
language | eng |
recordid | cdi_proquest_miscellaneous_2271854961 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals |
subjects | Acute Kidney Injury - prevention & control Aspirin - administration & dosage Cause of Death Coma - etiology Coronary Artery Bypass - adverse effects Heart Arrest - etiology Heart Block - etiology Heart Valve Prosthesis Implantation - adverse effects Humans Ischemic Attack, Transient - etiology Myocardial Infarction - etiology Observational Studies as Topic Platelet Aggregation Inhibitors - administration & dosage Postoperative Complications - etiology Postoperative Complications - prevention & control Randomized Controlled Trials as Topic |
title | A Meta-Analysis of Randomized and Observational Studies: Aspirin Protects from Cardiac Surgery-Associated Acute Kidney Injury |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-31T00%3A13%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Meta-Analysis%20of%20Randomized%20and%20Observational%20Studies:%20Aspirin%20Protects%20from%20Cardiac%20Surgery-Associated%20Acute%20Kidney%20Injury&rft.jtitle=The%20Heart%20surgery%20forum&rft.au=Liu,%20Huijiao&rft.date=2019-07-25&rft.volume=22&rft.issue=4&rft.spage=E301&rft.epage=E307&rft.pages=E301-E307&rft.issn=1098-3511&rft.eissn=1522-6662&rft_id=info:doi/10.1532/hsf.2419&rft_dat=%3Cproquest_cross%3E2271854961%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2271854961&rft_id=info:pmid/31398097&rfr_iscdi=true |